FdaApplication

NDA 021652

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVIIV HEALTHCARE CO
application_typeNDA
approval_date2004-08-02

Products (1)

ProductActive ingredientStrengthDosage form
EPZICOMABACAVIR SULFATE; LAMIVUDINEEQ 600MG BASE;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

1 product